China's CanSino requests emergency use approval for vaccine in Brazil

Samdech Thipadei Thanks Citizens for Supporting the Funan Techo Canal Project, Enabling Cambodia to Achieve Independence in Waterway Transport * PM: Funan Techo Canal Project Serves All Cambodians * PM Manet Thanks Citizens for Supporting the Funan Techo Canal Project * Cambodia Can Proceed with Funan Techo Canal without Seeking Approval from Other Countries, PM Cites the 1995 Mekong Agreement * PM Hun Manet Urges Three-generation Traitor Sam Rainsy to Prioritise National Interests * Cambodia Determined to Build the Funan Techo Canal Project Despite Challenge of Securing Foreign Investment, Says PM Hun Manet * TOP NEWS: Cambodia Reports 8 New COVID19 Cases; 0 Recovered; 0 Died * ASEAN Bazaar 2024: Celebrating Unity and Diversity in Cambodia

: Created: 11 November 2021; Hits: 3576

SAO PAULO, Nov 10 (Reuters) - China's CanSino Biologics Inc (6185.HK) has applied for emergency use authorization in Brazil for its COVID-19 vaccine, Brazil's health regulator Anvisa said on Wednesday.

Anvisa canceled an earlier request from CanSino in June after the laboratory cut ties with its Brazilian representative Belcher Farmaceutica Ltda.

Anvisa said the latest application had been made by Biomm, who was now representing CanSino.

CanSino's Convidecia is a single dose vaccine.

www.en.freshnewsasia.com

www.en.freshnewsasia.com

www.en.freshnewsasia.com